Personalized tumor antigen-specific TCR cloning platform

TCRCure conducts bioinformatics analyses to predict and obtain the neoantigen library from individual patients. By utilizing personalized tumor transcriptome data, TCRCure’s proprietary algorithms are designed to identify high-affinity and highly-presented tumor antigens. Using antigenic peptide stimulation or ex-vivo cancer vaccine strategies, TCRCure can screen for TCRs with functional activity against the tumor antigen. Highly reactive TCRs can be cloned and assembled into TCR-T constructs to generate therapeutic products.



Los Angeles California

Address:  5370 Alhambra Ave Ste F, Los Angeles, CA 90032, USA


Durham North Carolina

Address: 701 West Main St. Suite 200, Durham 27701 USA



Thank you for coming to TCRCure, if you have the intention of cooperation, please leave us a message or use the following ways to contact us, and to provide you with the most sincere professional services, thank you.


© 2017 Chongqing TCRCure Biological Technology Co Ltd. All Rights Reserved.  渝ICP备17005995号  Powered by: www.300.cnManager